“…MiR-365a-3p has been reported as substantially downregulated in breast, gastric, and HCC cancers [ 33 , 34 ]. Delivering naked miRNA to target tissue is difficult due to endosomal entrapment, enzymatic degradation in body fluids, and immune surveillance [ [35] , [36] , [37] , [38] , [39] , [40] ]. Therefore, using proper carriers can enhance the stability, permeability, and efficiency of tumor suppressor microRNA transfection.…”